Qianping Liang

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 17, 2022
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.

Qianping Liang, Feifei Chu, Lei Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Feifei Chu

1 joint publications

Lei Zhang

1 joint publications

Yuanyuan Jiang

1 joint publications

Lu Li